Evercore ISI analyst Vijay Kumar raised the firm’s price target on Exact Sciences (EXAS) to $70 from $60 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech, Life ...

180 Life Sciences (ATNF) announced that it has entered into a securities purchase agreement with several institutional investors to sell 1,200,000 shares of common stock in a registered direct ...

Caris Life Sciences (NASDAQ:CAI) is scheduled to make its trading debut on Wednesday on the Nasdaq after the Irving, Texas-based cancer diagnostics company priced its initial public offering at $21.00 ...

Cassava Sciences' stock price jumped 15.5% to $27.13, driven by rising short interest, which now accounts for 35.89% of the total float. he company will hold a conference call on August 8 to discuss ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. If you are wondering whether Exact Sciences at around US$103 a share still offers ...

) has been revised to $48.45 / share. This is an increase of 13.10% from the prior estimate of $42.84 dated December 18, 2025. The price target is an average of many targets provided by analysts. The ...

Truist lowered the firm’s price target on Integra LifeSciences (IART) to $13 from $15 and keeps a Hold rating on the shares. The firm notes it was surprised to see a Q3 revenue miss following multiple ...